{"title":"Role of ERG3 mutation and expression in azole resistant Candida albicans isolated from vulvovaginal candidiasis patients.","authors":"Ronaq Zaman, Ihsan Ullah, Ambreen Arif","doi":"10.12669/pjms.41.3.9325","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The study aimed to investigate mutations and mRNA expression of the <i>ERG3</i> gene in resistant <i>Candida albicans</i> isolates.</p><p><strong>Methods: </strong>This cross-sectional study was conducted from October 2018 to June 2019. High vaginal swab samples were collected from Hayatabad Medical Complex and transported to Khyber Medical University. Samples were inoculated on different media and identified by 20C AUX strips. Antifungal susceptibility was determined using the disc diffusion and broth microdilution methods. The <i>ERG3 gene</i> was amplified and sequenced to find amino acid polymorphisms. Real-time PCR was performed to study level of <i>ERG3</i> expression.</p><p><strong>Results: </strong>A total of seventy-three (n=73) C<i>andida albicans</i> out of 369 samples were isolated. Among the isolates 49.3%, 54.8%, 53.4%, 47.9%, 30.1% were resistant to fluconazole, Clotrimazole, Miconazole, Voriconazole and Itraconazole, respectively. Sanger sequencing of <i>ERG3</i> gene of isolates revealed six synonymous mutations. Expression level of mRNA of <i>ERG3</i> gene in azoles sensitive stains (3.72±2.22) was higher than those in the resistant <i>Candida albican</i> strains (1.74±0.96).</p><p><strong>Conclusion: </strong>This study revealed synonymous mutations and low expression of <i>ERG3</i> gene in azole-resistant <i>C. albican</i>.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"41 3","pages":"861-866"},"PeriodicalIF":1.2000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11911723/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan Journal of Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12669/pjms.41.3.9325","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The study aimed to investigate mutations and mRNA expression of the ERG3 gene in resistant Candida albicans isolates.
Methods: This cross-sectional study was conducted from October 2018 to June 2019. High vaginal swab samples were collected from Hayatabad Medical Complex and transported to Khyber Medical University. Samples were inoculated on different media and identified by 20C AUX strips. Antifungal susceptibility was determined using the disc diffusion and broth microdilution methods. The ERG3 gene was amplified and sequenced to find amino acid polymorphisms. Real-time PCR was performed to study level of ERG3 expression.
Results: A total of seventy-three (n=73) Candida albicans out of 369 samples were isolated. Among the isolates 49.3%, 54.8%, 53.4%, 47.9%, 30.1% were resistant to fluconazole, Clotrimazole, Miconazole, Voriconazole and Itraconazole, respectively. Sanger sequencing of ERG3 gene of isolates revealed six synonymous mutations. Expression level of mRNA of ERG3 gene in azoles sensitive stains (3.72±2.22) was higher than those in the resistant Candida albican strains (1.74±0.96).
Conclusion: This study revealed synonymous mutations and low expression of ERG3 gene in azole-resistant C. albican.
期刊介绍:
It is a peer reviewed medical journal published regularly since 1984. It was previously known as quarterly "SPECIALIST" till December 31st 1999. It publishes original research articles, review articles, current practices, short communications & case reports. It attracts manuscripts not only from within Pakistan but also from over fifty countries from abroad.
Copies of PJMS are sent to all the import medical libraries all over Pakistan and overseas particularly in South East Asia and Asia Pacific besides WHO EMRO Region countries. Eminent members of the medical profession at home and abroad regularly contribute their write-ups, manuscripts in our publications. We pursue an independent editorial policy, which allows an opportunity to the healthcare professionals to express their views without any fear or favour. That is why many opinion makers among the medical and pharmaceutical profession use this publication to communicate their viewpoint.